$3.79+0.06 (+1.61%)
Q/C Technologies, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets.
Q/C Technologies, Inc. in the Technology sector is trading at $3.79. The stock is currently near its 52-week low of $2.50, remaining 24.0% below its 200-day moving average. Technical signals show neutral RSI of 52 and bullish MACD crossover, explaining why QCLS maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Q/C Technologies, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets. The company develops Isomyosamine, a clinical stage small molecule that regulates t...